Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.
Saved in:
| Title: | Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies. |
|---|---|
| Authors: | Hutten SJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Chao X; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Badoux M; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Eijkman T; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Sheinman M; Institute of Advanced Studies, Sevastopol State University, Sevastopol, Russia., de Bruijn R; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands., Herencia-Ropero A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain.; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain., Llop-Guevara A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain., Lutz C; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Division of Diagnostic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam 1066CX, Netherlands., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona 08035, Spain., van Rheenen J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Scheele CLGJ; Center for Cancer Biology, VIB, Department of Oncology, KU Leuven, Leuven 3000, Belgium., Jonkers J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam 1066CX, Netherlands.; Oncode Institute, Amsterdam, Netherlands. |
| Corporate Authors: | Grand Challenge PRECISION Consortium |
| Source: | Science translational medicine [Sci Transl Med] 2026 Mar 18; Vol. 18 (841), pp. eads9088. Date of Electronic Publication: 2026 Mar 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.ads9088 |
